Abstract:Background: Multiple sclerosis (MS) is an immune-mediated central nervous system disease characterized by inflammation, demyelination and axonal degeneration. The pathology of MS suggests an autoimmune cause involving cellular and humoral components of the immune system. Active MS lesions are characterized by T-cell and macrophage infiltration and the presence of immune mediators, including adhesion molecules, chemokines, and cytokines. Cytokines are proven mediators of immunological process in MS. The aim of this study was to delineate the serum cytokine profile in patients with MS and the controls and to determine in different clinical forms of MS. Methods: This study involved 62 consecutive MS patients--28 patients with progressive MS and 34 patients with relapsing-remitting MS (RRMS). The control group consisted of 18, age and sex matched, non-immunological, neurological patients. The patients were evaluated using the Expanded Disability Status Scale (EDSS) and magnetic resonance imaging (MRI) with gadolinium. Serum samples for cytokine measurements were collected on admission. Plasma levels of proinflammatory T-helper (TH)1 (interferon (IFN)-γ) cytokines, peripheral monokines (IL-1beta, IL-6, TNF-alpha) and anti-inflammatory or down-regulatory TH2 cytokines (IL-4, IL-10) were determined by an enzyme-linked immunosorbent assay (ELISA) method. Results: All patients with MS had significantly higher cytokine (IFN-γ, IL-1β, IL-6, TNF-α, IL-4, IL-10) concentrations compared with controls (p < 0.001). Increased IL1beta, IFN-γ (p=0.032 and 0.041, respectively) and decreased IL-4, IL-10 (p=0.038 and 0.02, respectively) levels were found in progressive MS compared with RRMS. Patients with progressive MS with disease progression presented higher IL-1beta, TNF-alpha, IFN-γ and IL-10 levels than those without disease progression (p < 0.05). There was a significant inverse correlation between IL-10 levels and EDSS score in patients with progressive MS (R = 0.43, p < 0.05). Conclusion: Profiling cytokines in multiple sclerosis may help to identify mechanisms involved in the pathogenesis of the disease, and, potentially, lead to new therapies directed at cytokines or their receptors. The level of IL-10 can serve as an additional diagnostic criterion for assessing the disability in patients with progressive MS.

Investigation of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor concentrations in serum and cerebral spinal fluid in patients of clinically isolated syndrome

Investigation of Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor Concentrations in Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis and Neuromyelitis Optica

Concentrations of Vascular Endothelial Growth Factor in Serum and Cerebrospinal Fluid of Patients with Clinically Isolated Syndrome

Progression predictors of clinically isolated syndrome to multiple sclerosis: A prospective study in China

Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.

Serum Immunoglobulin G Level and Neutrophils to Lymphocytes Ratio Associated with the Prognosis of Neuromyelitis Optica Spectrum Disorder.

Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis.

Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.

Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction

Analysis of Factors Correlated with Spinal Clinically Isolated Syndrome Conversion to Multiple Sclerosis.

A-100 Selected pro-and anti-inflammatory cytokine serum concentrations in different clinical forms of multiple sclerosis

Serum and cerebrospinal fluid BDNF concentrations are associated with neurological and cognitive improvement in multiple sclerosis: A pilot study

Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis

Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients

Spinal Clinically Isolated Syndromes:Clinical and MRI Analysis

Functional Brain Network Alterations in Clinically Isolated Syndrome and Multiple Sclerosis: A Graph-based Connectome Study.

Cerebrospinal Fluid Level of Soluble CD27 Is Associated with Disease Severity in Neuromyelitis Optica Spectrum Disorder.

Analysis of oligocional band, IgG index and IgG synthesis rate in patients with multiple sclerosis

Relationship Of Csf And Serum Fgf-2 Level With Clinical Parameters In Motor Neuron Disease Patients

Whole brain functional connectivity in clinically isolated syndrome without conventional brain MRI lesions

Effects of Mesenchymal Stem Cell Transplantation on Cerebrospinal Fluid Biomarkers in Progressive Multiple Sclerosis